These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. Goldberg IE; Rossi GC; Letchworth SR; Mathis JP; Ryan-Moro J; Leventhal L; Su W; Emmel D; Bolan EA; Pasternak GW J Pharmacol Exp Ther; 1998 Aug; 286(2):1007-13. PubMed ID: 9694962 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2. Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196 [TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain. Fichna J; Janecka A; Bailly L; Marsais F; Costentin J; do Rego JC Chem Biol Drug Des; 2006 Sep; 68(3):173-5. PubMed ID: 17062015 [TBL] [Abstract][Full Text] [Related]
11. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. LaVigne J; Keresztes A; Chiem D; Streicher JM Pharmacol Rep; 2020 Apr; 72(2):465-471. PubMed ID: 32112361 [TBL] [Abstract][Full Text] [Related]
12. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Hackler L; Zadina JE; Ge LJ; Kastin AJ Peptides; 1997; 18(10):1635-9. PubMed ID: 9437727 [TBL] [Abstract][Full Text] [Related]
13. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ Biochem Biophys Res Commun; 1997 Jun; 235(3):567-70. PubMed ID: 9207197 [TBL] [Abstract][Full Text] [Related]
14. Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice. Sánchez-Blázquez P; Rodríguez-Díaz M; DeAntonio I; Garzón J J Pharmacol Exp Ther; 1999 Oct; 291(1):12-8. PubMed ID: 10490881 [TBL] [Abstract][Full Text] [Related]
15. Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants. Abbadie C; Rossi GC; Orciuolo A; Zadina JE; Pasternak GW Eur J Neurosci; 2002 Sep; 16(6):1075-82. PubMed ID: 12383236 [TBL] [Abstract][Full Text] [Related]
16. Saturable brain-to-blood transport of endomorphins. Kastin AJ; Fasold MB; Smith RR; Horner KA; Zadina JE Exp Brain Res; 2001 Jul; 139(1):70-5. PubMed ID: 11482845 [TBL] [Abstract][Full Text] [Related]
17. [Opioid receptors and their selective ligands]. Piestrzeniewicz MK; Fichna J; Janecka A Postepy Biochem; 2006; 52(3):313-9. PubMed ID: 17201067 [TBL] [Abstract][Full Text] [Related]
18. Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief. Janecka A; Gentilucci L Future Med Chem; 2014; 6(18):2093-101. PubMed ID: 25531970 [TBL] [Abstract][Full Text] [Related]
19. Endomorphin derivatives with improved pharmacological properties. Varamini P; Blanchfield JT; Toth I Curr Med Chem; 2013; 20(22):2741-58. PubMed ID: 23590712 [TBL] [Abstract][Full Text] [Related]
20. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]